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Source/Description: An Alu sequence with an (AAAAT)8 at the
3' end was identified in the first intron of the TP53 gene at
position 8703 ofEMBL accession no. X54156 (1). Primers that
uniquely amplified this Alu element were designed for the
polymerase chain reaction. The simple sequence repeat
polymorphism was detected by primer extension of a radiolabeled
consensus Alu primer (2). The predicted length of the radiolabeled
product for the (AAAAT)8 repeat was 120 bp.
Primer Sequences: P53ivsla: GCACTTTCCTCAACTCTACA;
P53ivslb: AACAGCTCCTTTAATGGCAG; ALE3 (consensus
Alu primer, ref. 3): CCA(C/T)TGCACTCCAGCCTGGG.










Estimated from 50 chromosomes of unrelated








Chromosomal Location: The p53 gene has been assigned to
17pl3.1 (4).
Mendelian Inheritance: Co-dominant segregation was observed
in a 12 member, 3 generation pedigree.
PCR Conditions: Conditions for the initial amplification were 50
ng genomic DNA, 1 AM each of P53ivsla and P53ivslb, 1 xPCR
buffer (Perkin Elmer Cetus), 200 AM dNTPs, and 0.5 units of
Amplitaq DNA polymerase in a 20 Mt1 reaction volume. The
reactions were processed through 27 cycles of 1 min at 94°C,
1 min at 55°C, and 1 min at 72°C. One pil of this reaction was
extended in a 20 1l reaction containing 1 AM ALE3 labeled with
T4 polynucleotide kinase. This final cycle consisted of 1 min at
94°C, 2 min at 55°C, and 3 min at 72°C. Allele sizes were
determined by comparison to M13mp18 sequencing ladders on
6% denaturing polyacrylamide gels. The repeat sequence in
X54156 was of the form (AAAAT)8-
Other Comments: This marker is useful for the detection of TP53
allele loss in tumors.
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Source/Description: Probe phD2 -244 containing a 3.8 kb XbaI
fragment inserted in the XbaI site of Bluescript. Insert contains
all of exon 3, about 150 bp of intron 3, and about 3 kb of intron
2 (1).
Polymorphism: TaqI identifies a two-allele polymorphism with
fragments at 3.1 kb (DI) and 1.75 and 1.3 (D2). Constant
fragments are at 1.4 and 0.8 kb.
Frequency: Estimated in 39 unrelated Caucasians
D1: 0.61
D2: 0.39
Observed heterozygosity = 0.58.
Chromosomal Location: Localized on chromosome 11 at q22 -23
by in situ hybridization (2).
Mendelian Inheritance: Co-dominant segregation was observed
in 20 informative Caucasian families (See Figure).
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